Reata Pharmaceuticals Inc

MetLife Investment Management, LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

4/29/2024

Shares

15,065

Value ($000)

1,536

Weight

0.0%

2018 Q3 - 2023 Q2 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	4/29/2024	1,536	0.0%	15,065	6/30/2023
2023 Q1	5/9/2024	1,313	0.0%	14,445	3/31/2023
2022 Q4	5/10/2024	569	0.0%	14,971	12/31/2022
2022 Q3	5/10/2024	392	0.0%	15,591	9/30/2022
2022 Q2	5/10/2024	474	0.0%	15,591	6/30/2022
2022 Q1	5/10/2024	511	0.0%	15,591	3/31/2022
2021 Q4	5/17/2024	259	0.0%	9,837	12/31/2021
2021 Q3	5/17/2024	990	0.0%	9,837	9/30/2021
2021 Q2	5/17/2024	1,392	0.0%	9,837	6/30/2021
2020 Q1	7/12/2023	1,372	0.0%	9,507	3/31/2020
2019 Q4	7/12/2023	1,944	0.0%	9,507	12/31/2019
2019 Q3	7/12/2023	732	0.0%	9,122	9/30/2019
2019 Q2	7/12/2023	861	0.0%	9,122	6/30/2019
2019 Q1	7/13/2023	716	0.0%	8,381	3/31/2019
2018 Q4	7/13/2023	470	0.0%	8,381	12/31/2018
2018 Q3	7/13/2023	685	0.0%	8,381	9/30/2018